Le Lézard14h
Statement from the Independent Medical Alliance on Speaker Johnson Announcing Intentions to Investigate Last Minute Fauci Pardon
Below is the statement from Lynne Kristensen, spokesperson for the Independent Medical Alliance (IMA) formerly the FLCCC Alliance, in response to Speaker Mike Johnson's comments today that he intends ...
Becker's Spine Review14h
5 medtech notes: Medtronic, Johnson and Johnson and more
From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.
Here’s Why Johnson & Johnson (JNJ) Is Among the Highest Yielding Dividend Stocks In the Dow
We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a ...
Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth
Johnson & Johnson unveiled financial results that beat Wall Street expectations as the company braces for one of its ...
Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer
Biodexa Strengthens Management TeamAppointment of Dr Gary A. Shangold as Chief Medical OfficerBiodexa Pharmaceuticals PLC ...
Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond
Says starting 2025 from a position of strength. Says invested ~$50B in R&D and M&A in 2024. Says continues to invest in R&D at ...
J&J Tops Q4 Adjusted Earnings Estimates, But 2025 Sales Outlook Falls Short
Johnson & Johnson posted its fourth-quarter earnings report Wednesday morning, with adjusted profits beating expectations ...
MassDevice23h
Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed
Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...